MYADMIA Trademark

Trademark Overview


On Monday, September 12, 2022, a trademark application was filed for MYADMIA with the United States Patent and Trademark Office. The USPTO has given the MYADMIA trademark a serial number of 97587826. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by Takeda Pharmaceuticals International AG. The MYADMIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy
myadmia

General Information


Serial Number97587826
Word MarkMYADMIA
Filing DateMonday, September 12, 2022
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7484496
Registration DateTuesday, August 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTakeda Pharmaceuticals International AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Party NameTakeda Pharmaceuticals International AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Party NameTakeda Pharmaceuticals International AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Trademark Events


Event DateEvent Description
Saturday, June 24, 2023NON-FINAL ACTION WRITTEN
Thursday, September 15, 2022NEW APPLICATION ENTERED
Thursday, September 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 24, 2023ASSIGNED TO EXAMINER
Saturday, June 24, 2023NON-FINAL ACTION E-MAILED
Saturday, June 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, November 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 27, 2024ASSIGNED TO LIE
Wednesday, March 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 1, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED